Company profile: NetraMark
1.1 - Company Overview
Company description
- Provider of AI-driven pharma-tech solutions for pharmaceutical and biotechnology companies, enabling the use of small to large datasets to optimize clinical trials and drug development through superior understanding of patient populations.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NetraMark
OpenQ
HQ: United States
Website
- Description: Provider of cloud-based technology and validated data enabling social and mobile collaboration to create competitive advantage while overcoming regulatory compliance challenges and legal risk exposure. Delivers the largest suite of solutions for regulated industries, serving life sciences, health care, and financial services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OpenQ company profile →
4G Clinical
HQ: United States
Website
- Description: Provider of software and services for clinical drug trials focused on randomization and trial supply management (RTSM), offering Prancer RTSM for complex and simple study randomization and supply, 4C Supply to manage supply chain risks, project patient demand, and adapt to protocol amendments, and Prancer RTSM Rand-Only for randomization-only patient tracking with blinded/unblinded site users.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4G Clinical company profile →
H1
HQ: United States
Website
- Description: Provider of a health data platform supporting end-to-end therapeutic development for medical companies and healthcare systems. Offerings include Trial Landscape for principal investigator pools, site performance and patient diversity insights; GenosAI for querying trial data; HCP Universe to discover and engage HCPs; Precise doctor directory data; and H1 Connect for global humanitarian missions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full H1 company profile →
Automata
HQ: United Kingdom
Website
- Description: Provider of workflow and robotic automation for life sciences labs, helping them innovate, diagnose and discover at scale, enabling faster results and scalable operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Automata company profile →
Insife
HQ: Denmark
Website
- Description: Provider of life science consulting and drug safety technology, offering HALOPV, an integrated platform for end-to-end pharmacovigilance (case intake, processing, regulatory compliance); HALOPV Enterprise for large-scale cloud environments; GRIP, a global regulatory intelligence subscription; an AI case intake solution; and a PSMF module that automates Pharmacovigilance System Master Files.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insife company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NetraMark
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NetraMark
2.2 - Growth funds investing in similar companies to NetraMark
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NetraMark
4.2 - Public trading comparable groups for NetraMark
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →